Exhibit 3.1
SECOND AMENDED AND RESTATED
BYLAWS
OF
COGNITION THERAPEUTICS, INC.
(the “Corporation”)

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4
For purposes of this Article I of these Bylaws, the term “Proposing Person” shall mean the following persons: (i) the stockholder of record providing the notice of nominations or business proposed to be brought before a stockholders’ meeting, and (ii) the beneficial owner(s), if different, on whose behalf the nominations or business proposed to be brought before a stockholders’ meeting is made. For purposes of this Article I of these Bylaws, the term “Nominating Person” shall mean (a) the stockholder providing the notice of the nomination proposed to be made at the meeting, (b) the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, and (c) any other participant in such solicitation. For purposes of this Section 1.2 of these Bylaws, the term “Synthetic Equity Interest” shall mean any transaction, agreement or arrangement (or series of transactions, agreements or arrangements), including, without limitation, any derivative, swap, hedge, repurchase or so-called “stock borrowing” agreement or arrangement, the purpose or effect of which is to, directly or indirectly: (a) give a person or entity economic benefit and/or risk similar to ownership of shares of any class or series of capital stock of the Corporation, in whole or in part, including due to the fact that such transaction, agreement or arrangement provides, directly or indirectly, the opportunity to profit or avoid a loss from any increase or decrease in the value of any shares of any class or series of capital stock of the Corporation, (b) mitigate loss to, reduce the economic risk of or manage the risk of share price changes for, any person or entity with respect to any shares of any class or series of capital stock of the Corporation, (c) otherwise provide in any manner the opportunity to profit or avoid a loss from any decrease in the value of any shares of any class or series of capital stock of the Corporation, or (d) increase or decrease the voting power of any person or entity with respect to any shares of any class or series of capital stock of the Corporation.

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4

ACTIVE/122224256.4
Adopted May 2, 2023 and effective as of May 2, 2023.

ACTIVE/122224256.4